Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

University of Cambridge in R&D pact with GSK
August 2012
SHARING OPTIONS:

CAMBRIDGE, United Kingdom—The University of Cambridge has announced the initiation of a program of scientific open collaboration with GlaxoSmithKline PLC (GSK). Teams of Cambridge scientists will work with GSK and other organizations to advance drug discovery and development. Cambridge Enterprise, the commercialization arm of the University of Cambridge, will facilitate the program. Researchers involved with the program will be based at Stevenage Bioscience Catalyst, which is located at GSK's research and development center.
 
"This open innovation approach is enabling scientists who might not ordinarily have interacted to build relationships, share ideas and seek advice. This environment provides us with an opportunity to stimulate research and translate science into the discovery of new medicines for patients," Patrick Vallance, president of Pharmaceuticals R&D at GSK, said in a press release.        
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.